Moneycontrol » News » Business » Business News

Pay-for-delay ban may be dropped from US Health Bill

Published on Fri, Mar 19, 2010 at 15:29 |  Source : CNBC-TV18

Updated at Fri, Mar 19, 2010 at 15:34  

54215 Investors following Ranbaxy Labs. Share this News with them.
0
0
Share on Tumblr
Pay-for-delay ban may be dropped from US Health Bill

RELATED NEWS

ALSO READ

Pay-for-delay ban is likely to be dropped from the US Healthcare Bill, reports CNBC-TV18. The provision was to bar out-of-court patent settlements.

The Federal Trade Commission (FTC) had sought curbs on out-of-court deals. It had proposed this provision in consumer interest.

Ranbaxy Laboratories , Lupin , Dr Reddy Laboratories , and Glenmark Pharmaceuticals are involved in patent litigations. The Healthcare Bill is to be voted over the weekend in the US Congress.

  

PREVIOUS STORY

Buy JK Lakshmi Cement: PPFAS

NEXT STORY

TCS to expand centers in N.America; CY12 focus on Japan

More on Moneycontrol
Headlines
view all »
Nifty holds morning gains; Reliance Infra tops buy list
12:43 PM
Nifty holds morning gains; Reliance Infra tops buy list
India's in a sweet spot now, says Credit Suisse
11:34 AM
India's in a sweet spot now, says Credit Suisse
Bharti has a problem with growing its volumes: JM Fin
12:44 PM
Bharti has a problem with growing its volumes: JM Fin
Greece, Budget, Credit Policy key triggers now: Jaipuria
09:51 AM
Greece, Budget, Credit Policy key triggers now: Jaipuria
Video of the day
Greece, Budget, Credit Policy key triggers now: Jaipuria
play
09:51 AM
Greece, Budget, Credit Policy key triggers now: Jaipuria
- in FII View
Sensex maintains uptrend; Asian cues positive
Listen Now!
Slideshows

Trending News

Business News

Tags: US Healthcare Bill, Pay-for-delay ban may be dropped from US Health Bill, Ranbaxy Laboratories, Glenmark Pharmaceuticals
Report hints at prototypes of the iTV in carriers' labs
Memo to FM: Ignore critics; this is the time to spend better "Memo to FM: Ignore critics; this is the time to spend better "

News

CBI To Request Malaysian Govt To Interrogate Owner Of Maxis Grp

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 8 2012, 13:30

India`s in a sweet spot now, says Credit Suisse

- in FII View

Feb 8 2012, 10:28

Multibagger ideas: India Glycol, TTK Healthcare

- in MARKET OUTLOOK

Interviews

Feb 8 2012, 12:46 | Source: CNBC-TV18

Tutorial business is doing well: Career Point  

Feb 8 2012, 11:01 | Source: CNBC-TV18

OMCs aiding airlines in ATF import unreasonable: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Explore Moneycontrol

STOCKS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
MUTUAL FUNDS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Unit Linked Insurance Plans (ULIPs) | | Budget: 2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | Union Budget | Budget 2012  | Economic Survey  | Railway Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide | History India  | Up Polls |  Latest News  | Mitt Romney | Bharti Airtel | BSE Sensex | Uninor | Iran | EGoM | Aviation | Thomas Cook | Mahindra and Mahindra Limited | Temasek Holdings
Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.